Raymond James Financial Services Advisors’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $179K | Sell |
25,818
-6,135
| -19% | -$42.6K | ﹤0.01% | 3206 |
|
|
2024
Q2 | $157K | Buy |
31,953
+6,197
| +24% | +$30.4K | ﹤0.01% | 3174 |
|
|
2024
Q1 | $149K | Sell |
25,756
-100
| -0.4% | -$580 | ﹤0.01% | 3156 |
|
|
2023
Q4 | $169K | Sell |
25,856
-372
| -1% | -$2.44K | ﹤0.01% | 3029 |
|
|
2023
Q3 | $126K | Sell |
26,228
-100
| -0.4% | -$482 | ﹤0.01% | 3023 |
|
|
2023
Q2 | $134K | Hold |
26,328
| – | – | ﹤0.01% | 3011 |
|
|
2023
Q1 | $145K | Buy |
26,328
+3,798
| +17% | +$20.9K | ﹤0.01% | 2985 |
|
|
2022
Q4 | $103K | Hold |
22,530
| – | – | ﹤0.01% | 3001 |
|
|
2022
Q3 | $141K | Hold |
22,530
| – | – | ﹤0.01% | 2930 |
|
|
2022
Q2 | $100K | Buy |
22,530
+700
| +3% | +$3.11K | ﹤0.01% | 2999 |
|
|
2022
Q1 | $110K | Sell |
21,830
-100
| -0.5% | -$504 | ﹤0.01% | 3080 |
|
|
2021
Q4 | $191K | Buy |
21,930
+300
| +1% | +$2.61K | ﹤0.01% | 2981 |
|
|
2021
Q3 | $202K | Sell |
21,630
-320
| -1% | -$2.99K | ﹤0.01% | 2971 |
|
|
2021
Q2 | $281K | Sell |
21,950
-325
| -1% | -$4.16K | ﹤0.01% | 2767 |
|
|
2021
Q1 | $205K | Buy |
+22,275
| New | +$205K | ﹤0.01% | 2886 |
|